Optimal use of biologic therapy for severe uncontrolled asthma rests on understanding of the disease itself. Try this quick quiz to test your knowledge.
Severe uncontrolled asthma remains a complex clinical challenge despite the emergence in recent years of novel biologic therapies. The authors of a comprehensive review and international expert opinion published this month in the Journal of Allergy and Clinical Immunology: In Practice, provide a set of essential clinical variables they believe are most relevant to managing severe asthma in adults and in optimizing the choice of biologic treatment.
The 5 questions that follow are based on the key factors they identify that go into effective treatment decision making.
FDA Proposed Rule Would Limit Nicotine Content in Cigarettes, Cigars, Other Combusted Products
January 16th 2025The agency estimates that limiting nicotine levels could lead to 1.8 million fewer tobacco-related deaths by 2060 and health care savings of $1.1 trillion a year over the next 40 years.